Third Party Payor Reimbursement. All billing practices of Seller with respect to the Facilities to all third party payors, including the Government Programs and private insurance companies, have been in material compliance with all Applicable Laws and all regulations and policies of such third party payors and Government Programs in all material respects. Seller has received no written notice that Seller has billed or received any payment or reimbursement in excess of amounts permitted by Applicable Law, except to the extent cured or corrected and all penalties or interest discharged in connection with such cure or correction.
Third Party Payor Reimbursement. All billing practices of Sonoma and its Subsidiaries with respect to the Sonoma Facilities and the Sonoma Management Properties, including practices with respect to Government Programs and private insurance companies, have been in compliance with all applicable Laws, regulations and policies of such Third Party Payors, except for any such noncompliances that have not been and would not reasonably be expected to be, individually or in the aggregate, material to Sonoma and its Subsidiaries, taken as a whole. Except as set forth on Section 2.21 of the Sonoma Disclosure Letter, since January 1, 2012: (a) none of Sonoma or any of its Subsidiaries has received written notice that Sonoma or any of its Subsidiaries has billed or received any payment or reimbursement that exceeds the amounts permitted by applicable Law by more than $500,000 individually, or $1,000,000 in the aggregate, except to the extent cured or corrected and all penalties or interest discharged in connection with such cure or correction and except for settling allowed amounts in the ordinary course of business; (b) none of Sonoma or any of its Subsidiaries has received written notice regarding a violation of or failure to comply with the billing requirements of a Government Program; and (c) there is no pending, nor to the Knowledge of Sonoma, any threatened, billing-related recoupment, proceeding or investigation under the Medicare or Medicaid program involving either Sonoma or any of its Subsidiaries, or any person who is an officer or director of Sonoma or any of its Subsidiaries, except in each case in clauses (b) and (c) where the result of such proceeding or investigation have not been or would not reasonably be expected to be, individually or in the aggregate, material to Sonoma and its Subsidiaries, taken as a whole.
Third Party Payor Reimbursement. All billing practices of each Seller with respect to its Facility to all third party payors, including the Government Programs and private insurance companies, have been in compliance with all Applicable Law, regulations and policies of such third party payors and Government Programs in all material respects. No Seller has received any written notice of, or to the Sellers’ knowledge any oral notice of, or has any knowledge, that it has billed or received any payment or reimbursement in excess of amounts permitted by Applicable Law, except to the extent cured or corrected (including all penalties or interest incurred in connection with such payment or reimbursement).
Third Party Payor Reimbursement. All billing practices of the Company and its Subsidiaries with respect to the Company Facilities, including the Government Programs (as defined below) and private insurance companies, have been in compliance with all applicable laws, regulations and policies of such third party payors and Government Programs, except where any failure to be in compliance has not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Except as set forth on Section 3.25 of the Company Disclosure Letter, since December 31, 2001, none of the Company or any of its Subsidiaries has received written notice that the Company or any of its Subsidiaries has billed or received any payment or reimbursement in excess of amounts permitted by applicable Law, except to the extent cured or corrected and all penalties or interest discharged in connection with such cure or correction. For purposes of this Agreement, "Government Programs" shall refer to Title XVIII ("Medicare") and Title XIX ("Medicaid") of the Social Security Act, CHAMPUS, TRICARE and other federal, state or local governmental reimbursement programs, or successor programs to any of the above.
Third Party Payor Reimbursement. All billing practices of the Weston Parties and their Subsidiaries with respect to the Rehabilitation Business to all third party payors, including the Government Programs and private insurance companies, have been in compliance with all applicable laws, regulations and policies of such third party payors and Government Programs.
Third Party Payor Reimbursement. All billing practices of Seller with respect to the Facility to all third party payors, including Medicare, Medicaid, CHAMPUS, TRICARE and other federal, state or local governmental reimbursement programs, or successor programs to any of the foregoing (collectively referred to herein as the “Government Programs”) and private insurance companies, have been in compliance with all Applicable Laws and policies of such third party payors and Government Programs in all respects. Seller has received no written notice that Seller has billed or received any payment or reimbursement in excess of amounts permitted by Applicable Law.
Third Party Payor Reimbursement. Since May 13, 2002, all billing practices of Sellers with respect to the Facilities to all third party payors, including the Government Programs and private insurance companies, have been in material compliance with all applicable laws, regulations and policies of such third party payors and Government Programs.
Third Party Payor Reimbursement. (a) All billing practices of the Company with respect to the Company Facilities to all third party payors, including the Government Programs and private insurance companies, have been in compliance with all applicable laws, regulations and policies of such third party payors and Government Programs, except as would not reasonably be expected to have a Company Material Adverse Effect. The Company has received no written notice that the Company has billed or received any payment or reimbursement in excess of amounts permitted by applicable law, regulations, or policies of third party payors and Government Programs, except to the extent cured or corrected and all penalties or interest discharged in connection with such cure or correction.
(b) The Company, its Subsidiaries and their senior management, officers and directors, have not been: (i) excluded from participating in any federal health care program (as defined in 42 U.S.C. §1320a-7b); (ii) subject to sanction pursuant to 42 U.S.C. §1320a-7a or 1320a-8; or (iii) convicted of a crime described in 42 U.S.C. §1320a-7b.
Third Party Payor Reimbursement. All billing practices of Parent with respect to the Parent Facilities to all third party payors, including the Government Programs and private insurance companies, have been in material compliance with all applicable laws, regulations and material policies of such third party payors and the Government Programs, except as set forth in the Parent SEC Reports and except as would not reasonably be expected to have a Parent Material Adverse Effect.
Third Party Payor Reimbursement. All billing practices of Parent and its Subsidiaries with respect to Parent Facilities, including the Government Programs (as defined below) and private insurance companies, have been in compliance with all applicable laws, regulations and policies of such third party payors and Government Programs, except where any failure to be in compliance has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect. Except as set forth on Section 4.25 of the Parent Disclosure Letter, since December 31, 2010, (i) none of Parent or any of its Subsidiaries has received written notice that Parent or any of its Subsidiaries has billed or received any payment or reimbursement that exceeds the amounts permitted by applicable Law by more than $10,000 individually, except to the extent cured or corrected and all penalties or interest discharged in connection with such cure or correction and except for billing and settling allowed amounts in ordinary course of business, (ii) none of Parent or any of its Subsidiaries has received written notice regarding a material violation of or failure to comply with the requirements of a Government Program; and (iii) there is no pending, nor to the Knowledge of Parent, any threatened, material proceeding or investigation under the Medicare or Medicaid program involving either Parent or any of its Subsidiaries, or any person who is an officer or director of Parent or any of its Subsidiaries, except in the case of (ii) and (iii) where any violation or failure to be in compliance, or the result of such proceeding or investigation, has not had and would not reasonably be expected to have, individually or in the aggregate, a Parent Material Adverse Effect.
